Status:
ACTIVE_NOT_RECRUITING
Smart Prostate Specific Antigen (PSA) Screening Study
Lead Sponsor:
University of Illinois at Chicago
Conditions:
PSA
Prostate Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This intervention includes the introduction of the Prostate Cancer Working Group (PCWG )Smart PSA Screening Guidelines and implementation of patient navigation/ care coordination for men with elevated...
Detailed Description
Primary care providers (PCP) hold the key to implementing effective early detection of Prostate Cancer (PCa), but uncertainty about how to use PSA for screening without causing undue overtreatment of ...
Eligibility Criteria
Inclusion
- Inclusion Criteria for PCP:
- PCP employed by MSHC who provides care for male adult patients
- Exclusion Criteria for PCP:
- Not a PCP employed by MSHC who provides care for male adult patients
- Inclusion Criteria for Patient navigator/care coordinator:
- Male
- Age 40-75
- Clinic visit at a MSHC site
- Elevated PSA (\>4.0 ng/ml)
- Exclusion Criteria for Patient navigator/care coordinator:
- • Not meeting the inclusion criteria
- Inclusion criteria for chart and database review:
- Male
- Age 40-75
- Clinic visit at a MSHC site from date of study start through 12 months (comparison of 12-month intervention period to periods before and after intervention implementation)
- Exclusion Criteria for chart and database review:
- • Not meeting the inclusion criteria
Exclusion
Key Trial Info
Start Date :
December 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2026
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT04782713
Start Date
December 17 2021
End Date
December 1 2026
Last Update
January 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mile Square Health Center
Chicago, Illinois, United States, 60612